SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* KAPOOR JOHN N (Last) (First) (Middle) 1925 WEST FIELD COURT SUITE 300 (Street) LAKE FOREST IL 60045 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol AKORN INC [ AKRX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 07/01/2016
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	07/01/2016		A		4,661	A	$0.00	505,391	D(2)
Common Stock								4,907,524	I	By Trust(3)
Common Stock								15,050,000	I	Indirect Managing General Partner(4)
Common Stock								2,970,644	I	Indirect Managing General Partner(5)
Common Stock								3,590,445	I	Indirect Managing General Partner(6)
Common Stock								4,427,462	I	By Trusts(7)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$29.5	07/01/2016		A		11,602		(8)	07/01/2023	Common Stock	11,602	$0.00	11,602	D

1. Name and Address of Reporting Person* KAPOOR JOHN N (Last) (First) (Middle) 1925 WEST FIELD COURT SUITE 300 (Street) LAKE FOREST IL 60045 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Akorn Holdings, L.P. (Last) (First) (Middle) 100 NORTH FIELD DRIVE SUITE 150 (Street) LAKE FOREST IL 60045 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The Restricted Stock Units vest in four equal installments with one installment vesting immediately on the grant date of July 1, 2016 and the remaining three installments vesting on July 1, 2017, July 1, 2018 and July 1, 2019. Following the reported transaction the amount of shares beneficially owned includes 3,495 unvested shares subject to restricted stock awards and 501,896 shares owned outright.

2. These securities are beneficially owned solely by Dr. John N. Kapoor, who is a member of a "group" with Akorn Holdings, L.P. for purposes of Section 13(d) of the Exchange Act.

3. Shares held by the John N. Kapoor Trust dated September 20, 1989, of which Dr. Kapoor is sole trustee and beneficiary.

4. Shares held by Akorn Holdings, LP, a Delaware limited partnership, of which Dr. Kapoor is the indirect managing general partner. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein.

5. Shares held by EJ Financial / Akorn Management L.P., a Delaware limited partnership, of which Dr. Kapoor is the indirect managing general partner. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein.

6. Shares held by EJ Funds LP, a Delaware limited partnership, of which Dr. Kapoor is the indirect managing general partner. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein.

7. Shares held through several trusts, the trustee of which is employed by a company controlled by Dr. Kapoor and the beneficiaries of which include Dr. Kapoor's children and various other family members. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein.

8. The Stock Options vest in four equal installments with one installment vesting immediately on the grant date of July 1, 2016 and the remaining three installments vesting on July 1, 2017, July 1, 2018 and July 1, 2019.

	/s/ Joseph Bonaccorsi, Attorney-in-fact for the Reporting Persons	07/06/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.